Education
About Us
Working with TipRanks
Follow Us
Privia Health Group (PRVA)
NASDAQ:PRVA
PRVA Stock Chart & Stats
$21.51
$0.26(1.28%)
At close: 4:00 PM EST
$21.51
$0.26(1.28%)
Day’s Range― - ―
52-Week Range$18.77 - $26.51
Previous CloseN/A
Volume48.95K
Average Volume (3M)615.67K
Market Cap
$2.71B
Enterprise Value$2.27B
Total Cash (Recent Filing)$441.35M
Total Debt (Recent Filing)$6.24M
Price to Earnings (P/E)151.5
Beta0.67
Next Earnings
Feb 26, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding123,001,526
10 Day Avg. Volume829,844
30 Day Avg. Volume615,673
Financial Highlights & Ratios
PEG Ratio-4.06
Price to Book (P/B)3.68
Price to Sales (P/S)1.34
P/FCF Ratio22.39
Enterprise Value/Market Cap0.84
Enterprise Value/Revenue1.11
Enterprise Value/Gross Profit11.21
Enterprise Value/Ebitda54.08
Forecast
1Y Price Target
$30.22Price Target Upside40.49% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial Strength And Strategic ExpansionRaised guidance, a strong cash position with no debt, and acquisitions like EVH ACO support geographic expansion and provide financial flexibility to boost future EBITDA.
Growth OutlookAnalyst highlights management's target for strong adjusted EBITDA growth in 2026, supported by continued provider additions, same-store expansion, and migration into higher-risk contracts that can drive scale.
Value-based Care ModelPrivia's disciplined value-based care approach aligns incentives with payers and providers, which should generate a steadier shared-savings revenue stream and reduce earnings volatility.
Bears Say
Earnings Estimate RiskAnalyst modestly lowered profit expectations to reflect more conservative assumptions about general and administrative expenses, creating downside pressure on near-term margins.
Sector Volatility And Investor SentimentOngoing sector volatility has dampened stock appreciation despite operational outperformance, increasing the risk of muted share gains even if company fundamentals remain strong.
Privia Health Group News
PRVA FAQ
What was Privia Health Group’s price range in the past 12 months?
Privia Health Group lowest stock price was $18.77 and its highest was $26.51 in the past 12 months.
What is Privia Health Group’s market cap?
Privia Health Group’s market cap is $2.71B.
When is Privia Health Group’s upcoming earnings report date?
Privia Health Group’s upcoming earnings report date is Feb 26, 2026 which is in 19 days.
How were Privia Health Group’s earnings last quarter?
Privia Health Group released its earnings results on Nov 06, 2025. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.054 by -$0.004.
Is Privia Health Group overvalued?
According to Wall Street analysts Privia Health Group’s price is currently Undervalued.
Does Privia Health Group pay dividends?
Privia Health Group does not currently pay dividends.
What is Privia Health Group’s EPS estimate?
Privia Health Group’s EPS estimate is 0.03.
How many shares outstanding does Privia Health Group have?
Privia Health Group has 123,001,526 shares outstanding.
What happened to Privia Health Group’s price movement after its last earnings report?
Privia Health Group reported an EPS of $0.05 in its last earnings report, missing expectations of $0.054. Following the earnings report the stock price went down -4.157%.
Which hedge fund is a major shareholder of Privia Health Group?
Currently, no hedge funds are holding shares in PRVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Privia Health Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$30.22 (40.49% Upside)
$30.22 (40.49% Upside)
Blogger Sentiment
Bullish
PRVA Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 245.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.6%
Last 30 Days ▲ 1.9%
Last 30 Days ▲ 1.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-7.99%
12-Months-Change
Fundamentals
Return on Equity
2.74%
Trailing 12-Months
Asset Growth
17.93%
Trailing 12-Months
Company Description
Privia Health Group
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
PRVA Company Deck
PRVA Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Privia Health's third-quarter earnings call highlighted strong financial performance, growth in attributed lives, and successful expansion plans. Despite challenges in the Medicare Advantage capitation model and conservative guidance for Q4, the company's overall results and strategic acquisitions position it well for future success.View all PRVA earnings summariesPRVA Stock 12 Month Forecast
Average Price Target
$30.22
▲(40.49% Upside)
Technical Analysis
Ownership Overview
1.92% Insiders
28.55% Mutual Funds
3.80% Other Institutional Investors
42.72% Public Companies and
Individual Investors